研究者
J-GLOBAL ID:201801019257914993   更新日: 2024年01月30日

細田 和貴

Hosoda Waki
所属機関・部署:
研究分野 (2件): 人体病理学 ,  腫瘍生物学
研究キーワード (4件): Next generation sequencing ,  Precursor lesions ,  Molecular Pathology ,  膵臓がん
競争的資金等の研究課題 (9件):
  • 2022 - 2025 多層プロテオーム解析による食道癌の新規治療標的探索と術前化学療法効果予測への応用
  • 2022 - 2025 KRAS変異陰性の腸型IPMNおよびコロイド癌におけるドライバー融合遺伝子の探索
  • 2021 - 2024 骨軟部肉腫の多層プロテオーム解析による病態解明と革新的治療法の開発
  • 2021 - 2024 胃癌PDXモデルの多層プロテオーム解析による革新的分子治療標的の同定
  • 2021 - 2024 インビトロ、インビボモデルの空間プロテオーム解析による大腸癌肝転移の分子機構解明
全件表示
論文 (55件):
  • Ayumi Kataoka, Masataka Sawaki, Nanae Horisawa, Haruru Kotani, Akiyo Yoshimura, Masaya Hattori, Yayoi Adachi, Kayoko Sugino, Yuka Endo, Yuri Ozaki, et al. ASO Visual Abstract: The Absence of Cancer in the Location of a Breast Tissue Marker After Neoadjuvant Chemotherapy May Predict Pathological Complete Response with High Accuracy-Results from a Phase II Trial. Annals of surgical oncology. 2023. 30. 6. 3235-3236
  • Ayumi Kataoka, Masataka Sawaki, Nanae Horisawa, Haruru Kotani, Akiyo Yoshimura, Masaya Hattori, Yayoi Adachi, Kayoko Sugino, Yuka Endo, Yuri Ozaki, et al. The Absence of Cancer in the Location of a Breast Tissue Marker After Neoadjuvant Chemotherapy may Predict Pathological Complete Response with High Accuracy: Results from a Phase II Trial. Annals of surgical oncology. 2023. 30. 6. 3224-3232
  • Masahiro Tajika, Tsutomu Tanaka, Sachiyo Oonishi, Keisaku Yamada, Tomoyasu Kamiya, Nobumasa Mizuno, Takamichi Kuwahara, Nozomi Okuno, Shin Haba, Yasuhiro Kuraishi, et al. Endoscopic Management of Adenomas in the Ileal Pouch and the Rectal Remnant after Surgical Treatment in Familial Adenomatous Polyposis. Journal of clinical medicine. 2022. 11. 12
  • Keiichiro Sakuma, Eiichi Sasaki, Waki Hosoda, Koji Komori, Yasuhiro Shimizu, Yasushi Yatabe, Masahiro Aoki. MYB mediates downregulation of the colorectal cancer metastasis suppressor heterogeneous nuclear ribonucleoprotein L-like during epithelial-mesenchymal transition. Cancer science. 2021. 112. 9. 3846-3855
  • Hiromi Furuta, Mitsugu Araki, Katsuhiro Masago, Yukari Sagae, Shiro Fujita, Katsutoshi Seto, Junichi Shimizu, Yoshitsugu Horio, Eiichi Sasaki, Waki Hosoda, et al. Novel Resistance Mechanisms Including L1196Q, P1094H, and R1248_D1249 Insertion in Three Patients With NSCLC After ALK Tyrosine Kinase Inhibitor Treatment. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2021. 16. 3. 477-482
もっと見る
MISC (10件):
  • Eiichi Sasaki, Katsuhiro Masago, Shiro Fujita, Hidenori Suzuki, Nobuhiro Hanai, Waki Hosoda. Salivary Secretory Carcinoma Harboring a Novel ALK Fusion: Expanding the Molecular Characterization of Carcinomas Beyond the ETV6 Gene. The American journal of surgical pathology. 2020
  • S. Hijioka, W. Hosoda, K. Matsuo, M. Ueno, M. Furukawa, H. Yoshitomi, M. Ikeda, T. Ito, N. Kobayashi, J. Furuse, et al. Pancreatic NET-G3 Does Not Respond to Platinum-Based Chemotherapy: A Multicenter Study of Neuroendocrine Carcinomas. NEUROENDOCRINOLOGY. 2017. 105. 186-186
  • Nobumasa Mizuno, Waki Hosoda, Keitaro Matsuo, Makoto Ueno, Masayuki Furukawa, Hideyuki Yoshitomi, Masafumi Ikeda, Noritoshi Kobayashi, Shoji Nakamori, Hiroshi Ishii, et al. Clinicopathological features and response to platinum-based chemotherapy (PBC) in pancreatic neuroendocrine carcinoma (pNEC): Updated results of Japan pNEC study. JOURNAL OF CLINICAL ONCOLOGY. 2016. 34. 15
  • Susumu Hijioka, Waki Hosoda, Keitaro Matsuo, Makoto Ueno, Masayuki Furukawa, Hideyuki Yoshitomi, Noritoshi Kobayashi, Masafumi Ikeda, Tetsuhide Ito, Shoji Nakamori, et al. Clinicopathological features and response to platinum-based chemotherapy in pancreatic neuroendocrine carcinoma: A retrospective multicenter study of 70 patients. JOURNAL OF CLINICAL ONCOLOGY. 2016. 34. 4
  • Toshiyuki Hasegawa, Kenji Yamao, Susumu Hijioka, Kazuo Hara, Nobumasa Mizuno, Tsutomu Tanaka, Shinya Kondo, Masahiro Tajika, Yasumasa Niwa, Hiroshi Imaoka, et al. Value of Endoscopic Ultrasonography (EUS) and Endoscope Ultrasound-Guided Fine-Needle Aspiration (EUS-FNA) for Histological Diagnosis and Assessment of Malignancy of Pancreatic Neuroendocrine Tumors (pNETs). GASTROINTESTINAL ENDOSCOPY. 2012. 75. 4. 193-193
もっと見る
書籍 (2件):
  • 腫瘍病理鑑別診断アトラス 胆道癌・膵癌
    文光堂 2015
  • 液状化検体細胞診断マニュアル
    篠原出版新社 2015
学歴 (4件):
  • 2015 - 2018 Johns Hopkins University/ Sol Goldman Pancreatic Cancer Research Center Department of Pathology Postdoctoral fellow
  • 1991 - 2015 Nagoya University Department of Biological Science Developmental Biology
  • 2010 - 2013 Nagoya University Graduate School of Medicine
  • 2005 - 2011 Shinshu University School of Medicine
経歴 (4件):
  • 2018/04 - 現在 Aichi Cancer Center
  • 2006/04 - 2015/05 Aichi Cancer Center Pathology and Molecular Diagnostics Attending Pathologist
  • 2002/04 - 2006/03 Shinshu University Laboratory Medicine Fellow
  • 2001/04 - 2002/03 Shinshi University Internal Medicine Resident
委員歴 (2件):
  • 2018/11 - 現在 日本臨床腫瘍学会 大腸がん遺伝子診療ガイダンス 作成委員
  • 2014 - 現在 日本病理学会 評議員
受賞 (2件):
  • 2017 - 中山がん研究所 海外留学生奨学金
  • 2016 - Sol Godman Pancreatic Cancer Research Center Sol Goldman Scholarship
所属学会 (6件):
UNITED STATES AND CANADIAN ACADEMY OF PATHOLOGY ,  日本膵臓学会 ,  日本臨床検査医学会 ,  日本臨床細胞学会 ,  日本病理学会 ,  International Aacademy of Pathology
※ J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。

前のページに戻る